Related Experiment Video
Updated: Nov 10, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Torasemide in Hypertension and Heart Failure: Re-inventing Loop Diuretic Therapy?
Athanasios Manolis1, Manolis Kallistratos1, Michael Doumas2
1Cardiology Department, Asklepeion Hospital, Athens, Greece.
Abstract:
In heart failure (HF) patients, current European Society of Cardiology (ESC) guidelines recommend the use of three loop diuretics (furosemide, torasemide, bumetanide) in order to not only reduce HF hospitalizations but also improve symptoms and exercise capacity in patients with signs and/or symptoms of congestion. In addition, for the first time in hypertensive patients, European Society of Hypertension (ESH) guidelines recommend the use of torasemide. This review aimed to summarize the mode of action of loop diuretics, to present their pharmacokinetic characteristics, and to discuss their place in the management of arterial hypertension and heart failure, with special emphasis however on torasemide.
Related Concept Videos
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Thiazide-Class Diuretics
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antihypertensive Drugs: Potassium-Sparing Diuretics

